# Ascendis Pharma A/S: Form D filing

Ascendis Pharma A/S, a pharmaceuticals company in Hellerup, Denmark, filed a Form D with the SEC in 2014. The latest, on December 9, 2014, reports $60 million sold of a $60 million offering to 11 investors.

Find out what Ascendis Pharma A/S does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Ascendis%20Pharma%20A%2FS%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Ascendis%20Pharma%20A%2FS&page=%2Fdata%2Fform-d%2Fcompany%2Fascendis-pharma-a-s-1612042)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Ascendis%20Pharma%20A%2FS%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Ascendis%20Pharma%20A%2FS&page=%2Fdata%2Fform-d%2Fcompany%2Fascendis-pharma-a-s-1612042)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: TUBORG BOULEVARD 12, Hellerup, Denmark, DK-29
- Phone: (453) 694-4486
- Industry: Pharmaceuticals
- Entity type: Other (Public Limited Liability Company)
- Incorporated in: Denmark
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1612042

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Dec 9, 2014 | New notice | $59,999,974 | $59,999,974 | $0 | 11 | Nov 24, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1612042/000114036114044520/0001140361-14-044520-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| James Wolff Healy | Director |  |
| Grethe Wolff Rasmussen | Executive Officer |  |
| Harald Wolff Rau | Executive Officer |  |
| Rafa?le Wolff Tordjman | Director |  |
| Martin Wolff Olin | Director |  |
| Jan M?ller Mikkelsen | Executive Officer, Director |  |
| Lotte Wolff S?nderbjerg | Executive Officer |  |
| Martin Wolff Auster | Executive Officer |  |
| Jonathan Wolff Silverstein | Director |  |
| Michael Wolff Jensen | Executive Officer, Director |  |
| Michael Wolff Mayer | Director |  |
| Edwin Wolff de Graaf | Director |  |
| Thomas Wolff Soloway | Executive Officer |  |
| Albert Wolff Cha | Director |  |

[Every Form D from the week of Dec 8, 2014](https://specstream.ai/data/form-d/week/2014-12-08) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Ascendis Pharma A/S reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).